Acrocraniofacial dysostosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:949OMIM:201050Q87.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Acrocraniofacial dysostosis is an extremely rare genetic condition that affects the development of the skull, face, and limbs. It belongs to a group of disorders called craniosynostosis syndromes, where one or more of the joints (sutures) between the bones of the skull close too early during a baby's development. This premature closure can affect the shape of the head and face and may put pressure on the growing brain. People with acrocraniofacial dysostosis typically have a distinctive facial appearance that may include a tall or pointed skull shape (called acrocephaly or turricephaly), widely spaced eyes, a flat or underdeveloped midface, and abnormalities of the hands and feet such as short fingers or fused digits. Some individuals may also experience intellectual disability, though this varies from person to person. Because this condition is so rare, there is limited published medical literature about it. Treatment is generally supportive and symptom-based. Surgery may be needed to correct skull shape, relieve pressure on the brain, or improve hand and foot function. A team of specialists including craniofacial surgeons, geneticists, and other healthcare providers typically manages care. Early diagnosis and intervention are important to optimize outcomes, particularly regarding brain development and function.

Also known as:

Key symptoms:

Abnormally shaped skull (tall or pointed head)Premature fusion of skull bonesWidely spaced eyesFlat or underdeveloped midfaceShort fingers or toesFused fingers or toes (webbing)Broad thumbs or big toesBulging or prominent eyesPossible intellectual disabilityPossible hearing lossDental abnormalitiesPossible breathing difficulties due to midface underdevelopmentPossible vision problems

Clinical phenotype terms (44)— hover any for plain English
Flared iliac wingHP:0002869
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Acrocraniofacial dysostosis.

View clinical trials →

No actively recruiting trials found for Acrocraniofacial dysostosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Acrocraniofacial dysostosis community →

No specialists are currently listed for Acrocraniofacial dysostosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Acrocraniofacial dysostosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Acrocraniofacial dysostosisForum →

No community posts yet. Be the first to share your experience with Acrocraniofacial dysostosis.

Start the conversation →

Latest news about Acrocraniofacial dysostosis

No recent news articles for Acrocraniofacial dysostosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is the craniosynostosis, and does my child need surgery soon?,Is there increased pressure on my child's brain, and how will you monitor this?,What surgeries might be needed, and what is the expected timeline?,Should we pursue genetic testing, and what would the results mean for our family?,What developmental milestones should I watch for, and when should I be concerned?,Are there therapies or early intervention programs that could help my child?,How often will my child need follow-up visits with each specialist?

Common questions about Acrocraniofacial dysostosis

What is Acrocraniofacial dysostosis?

Acrocraniofacial dysostosis is an extremely rare genetic condition that affects the development of the skull, face, and limbs. It belongs to a group of disorders called craniosynostosis syndromes, where one or more of the joints (sutures) between the bones of the skull close too early during a baby's development. This premature closure can affect the shape of the head and face and may put pressure on the growing brain. People with acrocraniofacial dysostosis typically have a distinctive facial appearance that may include a tall or pointed skull shape (called acrocephaly or turricephaly), wide

How is Acrocraniofacial dysostosis inherited?

Acrocraniofacial dysostosis follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Acrocraniofacial dysostosis typically begin?

Typical onset of Acrocraniofacial dysostosis is neonatal. Age of onset can vary across affected individuals.